Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
University of Cambridge · University of Miyazaki · +36 more institutions
Abstract
Abstract The SARS-CoV-2 Omicron BA.1 variant emerged in 2021 1 and has multiple mutations in its spike protein 2 . Here we show that the spike protein of Omicron has a higher affinity for ACE2 compared with Delta, and a marked change in its antigenicity increases Omicron’s evasion of therapeutic monoclonal and vaccine-elicited polyclonal neutralizing antibodies after two doses. mRNA vaccination as a third vaccine dose rescues and broadens neutralization. Importantly, the antiviral drugs remdesivir and molnupiravir retain efficacy against Omicron BA.1. Replication was similar for Omicron and Delta virus isolates in human nasal epithelial cultures. However, in lung cells and gut cells, Omicron demonstrated lower…
Citation impact
- FWCI
- 113.91
- Percentile
- 100%
- References
- 58
Authors
222Topics & keywords
- Virology
- Infectivity
- Virus
- Viral entry
- Biology
- Chemistry
- Viral replication
- Molecular biology
- Good health and well-being
Funding
- HHHoward Hughes Medical Institute
- BWBurroughs Wellcome Fund
- BABill and Melinda Gates FoundationAwards: OPP1156262, INV-018944
- TSTakeda Science Foundation
- NBNHS Blood and TransplantAward: WPA15-02
- JAJapan Agency for Medical Research and DevelopmentAwards: 20fk0108163, CREST, 21fk0410033, 20fk0108146, 20fk0108413, 20wm0325009, 20fk0108451, 21wm0325009
- WTWellcome TrustAwards: Z/17/Z, WT108082AIA, DEL-15-006, 207498, 207498/Z/17/Z
- TBTokyo Biochemical Research Foundation
- URUK Research and InnovationAward: MR/W005611/1
- FGFast Grants
- NINational Institute for Health and Care ResearchAwards: RG94028, 207498, RG85445
- DODepartment of Health and Social CareAward: HHSN272201700059C
- UOUniversity of Cambridge
- NUNewcastle University
- RTRosetrees Trust
- SASouth African Medical Research CouncilAwards: 6084-CO-AP-2020, DEL-15-006
- MFMitsubishi Foundation
- EAEuropean Association for the Study of the Liver
- NINational Institutes of HealthAwards: COVID-19, OPP1156262, HHSN272201700059C
- NBNIHR BioResource
- MRMedical Research CouncilAwards: MR/T032413/1, MR/P008801/1, MR/W005611/1, MC_PC_17230, MR/T032413/1, COVID-19
- EAEngineering and Physical Sciences Research CouncilAwards: EP/V002910/1, EP/V002910/1
- JSJapan Society for the Promotion of ScienceAwards: 18H02662, 18KK0447, JPJSCCA20190008, CREST, 21H02737, 19J20488, 19K06382
- RIResearch Institute for Microbial Diseases, Osaka University
- NINational Institute of General Medical SciencesAward: 5T32GM008268
- NINational Institute of Allergy and Infectious DiseasesAwards: HHSN272201700059C, COVID-19, DP1AI158186, OPP1156262
- IOInstitute of Genetics
- CRCore Research for Evolutional Science and TechnologyAward: JPMJCR20H4
- SIStrategic International Collaborative Research Program